The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1-Cubus Lux plc

21 Jan 2008 14:37

AIM21 January 2008 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES") COMPANY NAME:Cubus Lux plc COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :66 Wigmore StreetLondon W1U 2SB COUNTRY OF INCORPORATION:England and Wales COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:www.cubuslux.com COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITSINVESTING STRATEGY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BESTATED: The Cubus Lux Group currently comprises two trading subsidiaries, as well as other companies which hold or will be usedto acquire development projects in the future. The two trading subsidiaries are: Cubus Lux doo - which has a concession agreement for organising games of chance in casinos in Croatia, and currentlyoperates two year-round casinos in the Istrian Peninsula in northern Croatia - one in the Hotel Histria, Pula, and onein the Narcis Hotel, Rabac. Plava Vala doo - acquired by the Group in February 2006, which owns and operates the 200 berth Olive Island Marina onthe island of Ugljan, off the coast of Zadar, Croatia. The Group developed this marina which was opened in 2007. The Admission is sought as a result of the reverse takeover (under Rule 14) of two companies, Duboko Plavetnilo -Ugljan Projektant doo and Duboko Plavetnilo - Hoteli doo, which together own development projects which will result inthe development and sale of approximately 126 villas and 305 apartments on the island of Ugljan, together withamenities such as swimming pools, tennis courts, a marina, shops, bars, restaurants and a four star hotel.DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known,number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be heldas treasury shares):102,044,089 Ordinary Shares of 1 pence each, no restrictions. CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION: No capital to be raised on Admission. Anticipated Market Capitalisation £20.4 million PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:55.4% DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) AREOR WILL BE ADMITTED OR TRADED: None FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known orincluding any other name by which each is known): Gerhard Heribert Huber, executive chairman Stephen John McCann (known as Steve), finance director Christian Kaiser, chief operating officer Michael Martin Janssen, non executive director Leon Rodolfo Nahon, non executive director Haggai Ravid, non executive director Eliezer Abramovich, non executive director FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE ANDAFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known): Holding before Percentage of Holding after Percentage of admission issued share admission issued share capital before capital after admission admissionGerhard Heribert Huber 10,990,929 11.25% 12,212,602 11.97%Allveritas Inversiones SL 10,814,286 11.07% 10,814,286 10.60%Christian Kaiser 9,286,467 9.51% 9,286,467 9.10%Milan Kotur 7,866,667 8.05% 7,866,667 7.70%Kling GmbH 7,000,000 7.17% 7,670,095 7.52%Lucian Alter 3,299,588 3.38% 3,299,588 3.23%Xavier Azalbert 3,250,000 3.33% 3,250,000 3.18%Michael Janssen 3,219,000 3.30% 3,219,000 3.15%Stefan Roever 3,189,000 3.27% 3,189,000 3.13%Brada Investments Limited 3,024,762 3.10% 3,024,762 2.96%Active Management Fund I AG - - 3,405,000 3.34% NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:None (i) ANTICIPATED ACCOUNTING REFERENCE DATE (ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19: (i) 31 March (ii) 30 September 2007 (in respect of both the Company and the Targets) (iii) Annual accounts to 31 March 2008 to be published by 30 September 2008, half yearly report to 30 September 2008 to be published by 31 December 2008, annual accounts to 31 March 2009 to be published by 30 September 2009 EXPECTED ADMISSION DATE: 8 February 2008 NAME AND ADDRESS OF NOMINATED ADVISER: City Financial Associates Limited46 Worship StreetLondon EC2A 2EA NAME AND ADDRESS OF BROKER:Ellis Stockbrokers LimitedTalisman HouseJubilee WalkThree BridgesCrawleyWest Sussex RH10 1LQ Lewis Charles Securities Limited44 Worship StreetLondon EC2A 2EA OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILLBE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITSSECURITIES: The admission document will be available from www.cubuslux.com and it will contain full details about the applicant andthe admission of its securities DATE OF NOTIFICATION: 21 January 2008 NEW/ UPDATE: New This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.